Home » Biotechnology » Biomarkers Market

Global Biomarkers Market By Type (Safety, Efficacy, and Validation) By Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, and Others) By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, and Others)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the Report

How are the major segments performing in the Biomarkers market?

In 2022, the safety segment accounted for the largest share of the market. This segment is expected to grow as safety biomarkers are increasingly used in drug discovery & development.
In 2022, the drug discovery & development segment was anticipated to hold a prominent share of the global biomarkers market. Leading participants are putting in extensive R&D efforts; drug developers and strategic alliances are adopting biomarkers are being formed in biomarkers discovery to fuel segment growth.
In 2022, the cancer segment accounted for the largest share of the market. A rise in global cancer incidence and rapid & accurate diagnostic tools have contributed to the growth of this segment.

What is the Market Size of Biomarkers regarding value?

The global biomarkers market is anticipated to grow at a substantial CAGR of 13.80% in the upcoming years. The global biomarkers industry was estimated to be worth USD 67.9 billion in 2022 and was expected to be worth USD 167.8 billion by 2030.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Which region dominated the Biomarkers market?

In 2022, the North American region was anticipated to hold a prominent share of the global biomarkers market. The high prevalence of diseases, increased consumer awareness of biomarkers, government initiatives, technological advancements, and improvements in healthcare infrastructure have all contributed to this growth. Furthermore, the presence of key players and various organic & inorganic developments undertaken by these players will also contribute to the region’s growth. For example, Akoya Biosciences, Inc., announced their PhenoCode signature panels for discovering high-throughput spatial biomarkers in November 2022.

How is US Market Performing in the Biomarkers market?

As a result, the United States holds the largest share of the North American drug market. Over the last decade, the number of FDA-approved drug labels that contain information on molecular biomarkers has increased dramatically. In addition, chronic diseases continue to increase in prevalence in the United States, increasing the demand for effective and specific biomarkers. Approximately six out of ten adults in the United States have a chronic disease, and four out of ten adults have two or more chronic conditions, according to the National Center for Chronic Disease Prevention and Health Promotion’s article titled “Chronic Diseases in America,” published in January 2021. Since biomarkers are crucial for the early diagnosis and treatment of chronic diseases, the market for biomarkers is expected to grow significantly soon.

REPORT ATTRIBUTE	DETAILS
Biomarkers Market by Value	Yes
Biomarkers Market, Tornado Analysis	Yes
Biomarkers Market, STAR Analysis	Yes
Biomarkers Market, SRC Analysis	Yes
Biomarkers Market Pricing Analysis	Yes (On Demand)
Biomarkers Market Segment Analysis	By Type (Safety, Efficacy, and Validation) By Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, and Others) By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, and Others)
Biomarkers Market, Regional Analysis	North America (US and Canada) Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and the Rest of Asia Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and the Rest of Middle East and Africa)
Biomarkers Market Key Companies	F. Hoffmann-La Roche Ltd.; Abbott; Epigenomics AG; General Electric; Johnson & Johnson Services, Inc.; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; Siemens Healthcare GmbH; QIAGEN
Biomarkers Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted

How is the economy impacting the global Biomarkers growth?

The increase in COVID-19 patients accelerated the development of biomarker technologies. COVID-19 had a positive impact on the biomarker market. Chinese researchers identified SARS-CoV-2 infection by identifying molecular markers in the blood indicative of acute COVID-19 infection. There have been several infectious disease treatment procedures that require biomarkers for clinical decision-making. The National Center for Chronic Disease Prevention and Health Promotion published an article in January 2021 titled “Chronic Diseases in America” that indicates that approximately 6 out of 10 adults have a chronic disease, and 4 out of 10 have more than one chronic disease. In the near future, the market for biomarkers is expected to grow significantly due to the critical role biomarkers play in the early diagnosis and treatment of chronic diseases.

What is the competitive environment of the Biomarkers market?

The biomarkers industry’s competitive environment provides information on the economic profit made by suppliers and businesses, the sales and revenues created in this sector, the biomarkers market share globally, the business organization summary, the introduction of new products, and the opportunities for the industrial biomarkers market. For instance, in May 2021, due to the FDA approval of the KRAS G12C tissue companion diagnostic, QIAGEN N.V. expanded its lung cancer precision medicine portfolio by identifying the mutation in NSCLC tumors.

Executive Summary

What are the key trends in the Biomarkers market?

A growing number of smokers, unhealthy food consumers, and physically inactive people contribute to the increase in cancer burden. Biomarkers can indicate a range of health and disease aspects. As a result of multistage carcinogenesis and multiple molecular pathway events, cancer is a complex illness that poses challenges for diagnosis, prognosis, and treatment. The discovery of novel biomarkers offers new possibilities for developing treatment approaches designed to correct dysregulation in cancer since the disease is complicated and each type has its molecular profile. As a result, the market will grow due to the development of biomarker research and the rise in cancer incidence.

How are Manufacturers Teaming Up with Stakeholders in Biomarkers Market?

Several major factors are anticipated to fuel the demand for biomarkers during the forecast period, such as increased investments by industry players in the research and development of biomarkers and the launch of several tests in the market. Merck KGaA and Personalis, Inc., a leader in advanced genomics for cancer, entered into a collaboration in November 2019 to discover new biomarkers of response and resistance to cancer treatments. For the identification and development of clinical biomarkers, Personalis’ newest cancer immunogenomics platform, ImmunoID NeXT, will be used by Merck KGaA. In September 2019, Owlstone Medical Ltd introduced a new ReCIVA Breath Sampler and CASPER Portable Air Supply, expected to boost the market growth. Similar collaborations and partnerships are expected to propel the introduction of new products in the market.

Which are the key investments by the Biomarkers market players?

Leading players operating in the biomarkers market are focusing on expansion in production capacities for biomarkers. In addition to that, players are focusing on strategic mergers and acquisitions, collaborations, and creating awareness among manufacturers through various associations formed to promote smart practices in order to gain an advantage in the domestic market. For instance, in September 2020, As part of a collaboration with AstraZeneca and the University of Nebraska Medical Center, Thermo Fisher Scientific announced a collaboration to discover clinical biomarkers.

Some major players in the biomarkers market are F. Hoffmann-La Roche Ltd.; Abbott; Epigenomics AG; General Electric; Johnson & Johnson Services, Inc.; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; Siemens Healthcare GmbH; QIAGEN.

What are the Major Driving Factors for the Biomarkers Market?

It is due to several factors that the global biomarkers market is gaining traction, such as the rise of companion diagnostics and personalized medicine, the rapid growth of contract research organizations, the decrease in clinical trial costs in emerging economies, the high prevalence of cancer, the surge in biotechnology and pharmaceutical investment in research and development, and new initiatives in biomarker research that are boosting the market. While these markets are likely to open new revenue streams for companies in the global biomarkers industry, they must prove the validity of the tests in highly populated nations in the Asia Pacific, such as India and China.

What are the Major Risks for the Biomarkers Market?

Developing, validating, and discovering biomarkers requires enormous capital investments. This hinders the growth of the global market and other related markets, such as diagnostics (in vitro) and personalized medicine. There is far more discovery of candidate biomarkers than the capacity to validate them. Additionally, diagnostics manufacturers face enormous financial challenges because of the high failure rate of drugs in clinical trials.

Which is the key application in the Biomarkers market?

The drug discovery & development segment is expected to hold a prominent share of the global biomarkers market during the forecast period. Leading participants are engaging in extensive R&D efforts, using biomarkers in drug discovery is rising, and strategic alliances are underway in discovering biomarkers. InterVenn Biosciences, for example, collaborated with the Biomarker Consortium for the National Institutes of Health and Worldwide Innovative Network (WIN) Consortium in June 2022. As a result, clinical trials were improved, patient care was improved, precision oncology was enhanced, and biomarker discovery was accelerated. Tempus also extended its multi-year agreement with Janssen in June 2021 to enhance the development and discovery of oncology therapies through AI/ML and real-world evidence.

How is the Biomarkers market performing in regions?

Asia Pacific market is anticipated to witness the fastest growth in the global biomarkers market during the forecast period. Regional growth is expected to be supported by factors such as a surge in funding for biomarker discovery, high cancer prevalence, increasing research initiatives, and low clinical trial costs in developing countries. The regional market is expected to grow during the projected period due to increased funding for biotech and pharma companies, increased CROs, and a rise in the application scope of biomarkers.

What is the regulatory landscape for the Biomarkers market?

The growth of the global biomarkers market might be hindered by product recalls by market players or regulatory authorities during the forecast period. As an example, Meridian Bioscience, a life science company that develops, manufactures, markets and distributes a wide range of diagnostic products, voluntarily recalled its lead care test kits on September 1, 2021. According to Magellan, a subsidiary of Meridian Bioscience, the “Low-Control” and “High-Control” control tests produced “low” results, which led to the recall of these kits. Magellan started the recall because the affected Lead Care Test Kit batches could understate blood lead levels when processing patient blood samples.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the major players planning for the future of the Biomarkers market?

It is envisaged that investing in downstream applications and expanding regional presence would provide businesses a competitive edge. For instance, in April 2021, A series of five new uses for F. Hoffmann-La Roche Ltd’s cardiac biomarkers, powered by Elecsys technology, was announced recently. These biomarkers have been proven effective in the treatment of cardiovascular disease.

Segmentation of Global Biomarkers Market-

Global Biomarkers Market – By Type

Safety
Efficacy
Validation

Global Biomarkers Market – By Application

Diagnostics
Drug Discovery & Development
Personalized Medicine
Others

Global Biomarkers Market – By Disease

Cancer
Cardiovascular Diseases
Neurological Diseases
Immunological Diseases
Others

Global Biomarkers Market – By Region

North America
- U.S
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Biomarkers Market
2.2. Global Biomarkers Market, By Type
2.3. Global Biomarkers Market, By Application
2.4. Global Biomarkers Market, By Disease
2.5. Global Biomarkers Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Biomarkers Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Application
3.5.3. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Type Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Biomarkers Market
7.1. Global Biomarkers Market, by Type, 2017-2030 (US$ Bn)
7.1.1. Overview
7.1.2. Global Biomarkers Market, By Type, 2022 vs 2030 (in%)
7.1.3. Global Biomarkers Market, By Safety, 2017-2030 (US$ Bn)
7.1.4. Global Biomarkers Market, By Efficacy, 2017-2030 (US$ Bn)
7.1.5. Global Biomarkers Market, By Validation, 2017-2030 (US$ Bn)
7.2. Global Biomarkers Market, by Application, 2017-2030 (US$ Bn)
7.2.1. Overview
7.2.2. Global Biomarkers Market, By Application, 2022 vs 2030 (in%)
7.2.3. Global Biomarkers Market, By Diagnostics, 2017-2030 (US$ Bn)
7.2.4. Global Biomarkers Market, By Drug Discovery & Development, 2017-2030 (US$ Bn)
7.2.5. Global Biomarkers Market, By Personalized Medicine, 2017-2030 (US$ Bn)
7.2.6. Global Biomarkers Market, By Others, 2017-2030 (US$ Bn)
7.3. Global Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
7.3.1. Overview
7.3.2. Global Biomarkers Market, By Disease, 2022 vs 2030 (in%)
7.3.3. Global Biomarkers Market, By Cancer, 2017-2030 (US$ Bn)
7.3.4. Global Biomarkers Market, By Cardiovascular Diseases, 2017-2030 (US$ Bn)
7.3.5. Global Biomarkers Market, By Neurological Diseases, 2017-2030 (US$ Bn)
7.3.6. Global Biomarkers Market, By Immunological Diseases, 2017-2030 (US$ Bn)
7.3.7. Global Biomarkers Market, By Others, 2017-2030 (US$ Bn)

8. North America Biomarkers Market Analysis
8.1. North America Biomarkers Market, by Type, 2017-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Biomarkers Market, by Application, 2017-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Biomarkers Market, by Disease, 2017-2030(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Biomarkers Market, by Country, 2017-2030 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.4.1.2. U.S. Biomarkers, By Type, 2017-2030 (US$ Bn)
8.4.1.3. U.S. Biomarkers, By Application, 2017-2030 (US$ Bn)
8.4.1.4. U.S. Biomarkers, By Disease, 2017-2030 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.4.2.2. Canada Biomarkers, By Type, 2017-2030 (US$ Bn)
8.4.2.3. Canada Biomarkers, By Application, 2017-2030 (US$ Bn)
8.4.2.4. Canada Biomarkers, By Disease, 2017-2030 (US$ Bn)

9. Europe Biomarkers Market Analysis
9.1. Europe Biomarkers Market, by Type, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Biomarkers Market, by Application, 2017-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Biomarkers Market, by Disease, 2017-2030(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Biomarkers Market, by Country, 2017-2030 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.1.2. Germany Biomarkers, By Type, 2017-2030 (US$ Bn)
9.4.1.3. Germany Biomarkers, By Application, 2017-2030 (US$ Bn)
9.4.1.4. Germany Biomarkers, By Disease, 2017-2030 (US$ Bn)
9.4.2. France
9.4.2.1. France Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.2.2. France Biomarkers, By Type, 2017-2030 (US$ Bn)
9.4.2.3. France Biomarkers, By Application, 2017-2030 (US$ Bn)
9.4.2.4. France Biomarkers, By Disease, 2017-2030 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.3.2. UK Biomarkers, By Type, 2017-2030 (US$ Bn)
9.4.3.3. UK Biomarkers, By Application, 2017-2030 (US$ Bn)
9.4.3.4. UK Biomarkers, By Disease, 2017-2030 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.4.2. Italy Biomarkers, By Type, 2017-2030 (US$ Bn)
9.4.4.3. Italy Biomarkers, By Application, 2017-2030 (US$ Bn)
9.4.4.4. Italy Biomarkers, By Disease, 2017-2030 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.5.2. Spain Biomarkers, By Type, 2017-2030 (US$ Bn)
9.4.5.3. Spain Biomarkers, By Application, 2017-2030 (US$ Bn)
9.4.5.4. Spain Biomarkers, By Disease, 2017-2030 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.6.2. Rest of Europe Biomarkers, By Type, 2017-2030 (US$ Bn)
9.4.6.3. Rest of Europe Biomarkers, By Application, 2017-2030 (US$ Bn)
9.4.6.4. Rest of Europe Biomarkers, By Disease, 2017-2030 (US$ Bn)

10. Asia Pacific Biomarkers Market Analysis
10.1. Asia Pacific Biomarkers Market, by Type, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Biomarkers Market, by Application, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Biomarkers Market, by Disease, 2017-2030(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Biomarkers Market, by Country, 2017-2030 (US$ Bn)
10.4.1. China
10.4.1.1. China Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.1.2. China Biomarkers, By Type, 2017-2030 (US$ Bn)
10.4.1.3. China Biomarkers, By Application, 2017-2030 (US$ Bn)
10.4.1.4. China Biomarkers, By Disease, 2017-2030 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.2.2. Japan Biomarkers, By Type, 2017-2030 (US$ Bn)
10.4.2.3. Japan Biomarkers, By Application, 2017-2030 (US$ Bn)
10.4.2.4. Japan Biomarkers, By Disease, 2017-2030 (US$ Bn)
10.4.3. India
10.4.3.1. India Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.3.2. India Biomarkers, By Type, 2017-2030 (US$ Bn)
10.4.3.3. India Biomarkers, By Application, 2017-2030 (US$ Bn)
10.4.3.4. India Biomarkers, By Disease, 2017-2030 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.4.2. South Korea Biomarkers, By Type, 2017-2030 (US$ Bn)
10.4.4.3. South Korea Biomarkers, By Application, 2017-2030 (US$ Bn)
10.4.4.4. South Korea Biomarkers, By Disease, 2017-2030 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.5.2. South-East Asia Biomarkers, By Type, 2017-2030 (US$ Bn)
10.4.5.3. South-East Asia Biomarkers, By Application, 2017-2030 (US$ Bn)
10.4.5.4. South-East Asia Biomarkers, By Disease, 2017-2030 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.6.2. Rest of Asia Pacific Biomarkers, By Type, 2017-2030 (US$ Bn)
10.4.6.3. Rest of Asia Pacific Biomarkers, By Application, 2017-2030 (US$ Bn)
10.4.6.4. Rest of Asia Pacific Biomarkers, By Disease, 2017-2030 (US$ Bn)

11. Latin America Biomarkers Market Analysis
11.1. Latin America Biomarkers Market, by Type, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Biomarkers Market, by Application, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Biomarkers Market, by Disease, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Biomarkers Market, by Country, 2017-2030 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.1.2. Brazil Biomarkers, By Type, 2017-2030 (US$ Bn)
11.4.1.3. Brazil Biomarkers, By Application, 2017-2030 (US$ Bn)
11.4.1.4. Brazil Biomarkers, By Disease, 2017-2030 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. Mexico Biomarkers, By Type, 2017-2030 (US$ Bn)
11.4.2.3. Mexico Biomarkers, By Application, 2017-2030 (US$ Bn)
11.4.2.4. Mexico Biomarkers, By Disease, 2017-2030 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Rest of Latin America Biomarkers, By Type, 2017-2030 (US$ Bn)
11.4.3.3. Rest of Latin America Biomarkers, By Application, 2017-2030 (US$ Bn)
11.4.3.4. Rest of Latin America Biomarkers, By Disease, 2017-2030 (US$ Bn)

12. Middle East and Africa Biomarkers Market Analysis
12.1. Middle East and Africa Biomarkers Market, by Type, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Biomarkers Market, by Application, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Biomarkers Market, by Disease, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Biomarkers Market, by Country, 2017-2030 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.1.2. GCC Countries Biomarkers, By Type, 2017-2030 (US$ Bn)
12.4.1.3. GCC Countries Biomarkers, By Application, 2017-2030 (US$ Bn)
12.4.1.4. GCC Countries Biomarkers, By Disease, 2017-2030 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. South Africa Biomarkers, By Type, 2017-2030 (US$ Bn)
12.4.2.3. South Africa Biomarkers, By Application, 2017-2030 (US$ Bn)
12.4.2.4. South Africa Biomarkers, By Disease, 2017-2030 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Biomarkers Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Biomarkers, By Type, 2017-2030 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Biomarkers, By Application, 2017-2030 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Biomarkers, By Disease, 2017-2030 (US$ Bn)

13. Company Profiles
13.1. F. Hoffmann-La Roche Ltd.
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Abbott
13.3. Epigenomics AG
13.4. General Electric
13.5. Johnson & Johnson Services, Inc
13.6. Thermo Fisher Scientific Inc.
13.7. Bio-Rad Laboratories, Inc.
13.8. Siemens Healthcare GmbH
13.9. QIAGEN

List of Figures
FIG. 1 Global Biomarkers Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Biomarkers Market Segmentation
FIG. 4 Global Biomarkers Market, by Type, 2022 (US$ Bn)
FIG. 5 Global Biomarkers Market, by Application, 2022 (US$ Bn)
FIG. 6 Global Biomarkers Market, by Disease, 2022 (US$ Bn)
FIG. 7 Global Biomarkers Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Type, 2022
FIG. 9 Attractive Investment Proposition, by Application, 2022
FIG. 10 Attractive Investment Proposition, by Disease, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Biomarkers Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Biomarkers Market Manufacturers, 2022
FIG. 14 Global Biomarkers Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 15 Global Biomarkers Market, by Safety, Value, 2017-2030 (US$ Bn)
FIG. 16 Global Biomarkers Market, by Efficacy, Value, 2017-2030 (US$ Bn)
FIG. 17 Global Biomarkers Market, by Validation, Value, 2017-2030 (US$ Bn)
FIG. 18 Global Biomarkers Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 19 Global Biomarkers Market, by Diagnostics, Value, 2017-2030 (US$ Bn)
FIG. 20 Global Biomarkers Market, by Drug Discovery & Development, 2017-2030 (US$ Bn)
FIG. 21 Global Biomarkers Market, by Personalized Medicine, 2017-2030 (US$ Bn)
FIG. 22 Global Biomarkers Market, by Others, 2017-2030 (US$ Bn)
FIG. 23 Global Biomarkers Market Value Contribution, By Disease, 2022 & 2030 (Value %)
FIG. 24 Global Biomarkers Market, by Cancer, Value, 2017-2030 (US$ Bn)
FIG. 25 Global Biomarkers Market, by Cardiovascular Diseases, 2017-2030 (US$ Bn)
FIG. 26 Global Biomarkers Market, by Neurological Diseases, 2017-2030 (US$ Bn)
FIG. 27 Global Biomarkers Market, by Immunological Diseases, 2017-2030 (US$ Bn)
FIG. 28 Global Biomarkers Market, by Others, 2017-2030 (US$ Bn)
FIG. 29 North America Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 30 U.S. Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 31 Canada Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 32 Europe Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 33 Germany Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 34 France Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 35 U.K. Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 36 Italy Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 37 Spain Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 38 Rest of Europe Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 39 Asia Pacific Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 40 China Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 41 Japan Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 42 India Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 43 South Korea Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 44 South-East Asia Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 45 Rest of Asia Pacific Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 46 Latin America Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 47 Brazil Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 48 Mexico Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 49 Rest of Latin America Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 50 Middle East & Africa Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 51 GCC Countries Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 52 South Africa Biomarkers Market, 2017-2030 (US$ Bn)
FIG. 53 Rest of Middle East and Africa Biomarkers Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Biomarkers Market
TABLE 2 Global Biomarkers Market, by Competitive Benchmarking, 2022
TABLE 3 Global Biomarkers Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Biomarkers Market, by Key Strategies Analysis, 2022
TABLE 5 Global Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 6 Global Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 7 Global Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 8 Global Biomarkers Market, by Geography, 2017-2030 (US$ Bn)
TABLE 9 North America Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 10 North America Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 11 North America Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 12 North America Biomarkers Market, by Country, 2017-2030 (US$ Bn)
TABLE 13 US Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 14 US Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 15 US Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 16 Canada Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 17 Canada Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 18 Canada Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 19 Europe Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 20 Europe Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 21 Europe Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 22 Europe Biomarkers Market, by Country, 2017-2030 (US$ Bn)
TABLE 23 Germany Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 24 Germany Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 25 Germany Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 26 France Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 27 France Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 28 France Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 29 UK Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 30 UK Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 31 UK Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 32 Italy Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 33 Italy Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 34 Italy Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 35 Spain Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 36 Spain Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 37 Spain Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 38 Rest of Europe Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 39 Rest of Europe Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 40 Rest of Europe Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 41 Asia Pacific Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 42 Asia Pacific Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 43 Asia Pacific Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 44 Asia Pacific Biomarkers Market, by Country, 2017-2030 (US$ Bn)
TABLE 45 China Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 46 China Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 47 China Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 48 Japan Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 49 Japan Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 50 Japan Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 51 India Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 52 India Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 53 India Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 54 South Korea Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 55 South Korea Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 56 South Korea Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 57 South-East Asia Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 58 South-East Asia Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 59 South-East Asia Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 60 Rest of Asia Pacific Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 61 Rest of Asia Pacific Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 62 Rest of Asia Pacific Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 63 Latin America Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 64 Latin America Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 65 Latin America Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 66 Latin America Biomarkers Market, by Country, 2017-2030 (US$ Bn)
TABLE 67 Brazil Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 68 Brazil Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 69 Brazil Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 70 Mexico Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 71 Mexico Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 72 Mexico Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 73 Rest of Latin America Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 74 Rest of Latin America Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 75 Rest of Latin America Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 76 Middle East and Africa Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 77 Middle East and Africa Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 78 Middle East and Africa Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 79 Middle East and Africa Biomarkers Market, by Country, 2017-2030 (US$ Bn)
TABLE 80 GCC Countries Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 81 GCC Countries Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 82 GCC Countries Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 83 South Africa Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 84 South Africa Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 85 South Africa Biomarkers Market, by Disease, 2017-2030 (US$ Bn)
TABLE 86 Rest of Middle East and Africa Biomarkers Market, by Type, 2017-2030 (US$ Bn)
TABLE 87 Rest of Middle East and Africa Biomarkers Market, by Application, 2017-2030 (US$ Bn)
TABLE 88 Rest of Middle East and Africa Biomarkers Market, by Disease, 2017-2030 (US$ Bn)

Frequently Asked Questions

How does COVID-19 Impact the global Biomarkers market?

The increase in COVID-19 patients accelerated the development of biomarker technologies. COVID-19 had a positive impact on the biomarker market.

Which is the leading region of the market for Biomarkers?

North America accounted for the most heightened share in the global biomarkers market.

What are the key drivers for the growth of the Biomarkers market?

Growth of the industry is anticipated to be driven by the increasing importance of companion diagnostics, the rising prevalence of cancer, increased investments in biomarker research, and significant innovations due to ongoing research.

Which is the major segment in the Biomarkers market by type?

The safety segment had a major share in the global market in 2022.

Which is the major segment in the Biomarkers market by application?

The drug discovery & development segment had a major share in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –